IMMUNOCORE HLDGS ADS/1 Free Cash Flow Generation Index
IMMUNOCORE HLDGS ADS/1 free cash flow generation index. IMMUNOCORE HLDGS ADS/1 (6YG) has a Free Cash Flow Generation Index of 0.95x as of June 2026. Free cash flow of €15.14 Million represents 1% of operating cash flow (€15.93 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of IMMUNOCORE HLDGS ADS/1 (2023–2024)
Free cash flow generation index of IMMUNOCORE HLDGS ADS/1 from 2023 to 2024. Historical FCF Generation Index trend for IMMUNOCORE HLDGS ADS/1 across 2 annual periods. See 6YG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
IMMUNOCORE HLDGS ADS/1 Free Cash Flow Generation Index by Year (2023–2024)
IMMUNOCORE HLDGS ADS/1 free cash flow generation index by year from 2023 to 2024. Year-by-year Free Cash Flow Generation Index for IMMUNOCORE HLDGS ADS/1. For the full cash flow conversion analysis, see cash efficiency ratio of IMMUNOCORE HLDGS ADS/1.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.80x | €20.89 Million | €26.06 Million | €5.17 Million | ▲ +194.8% |
| 2023 | -0.85x | €-2.48 Million | €2.94 Million | €5.42 Million | — |